Tested Applications
| Positive WB detected in | mouse brain tissue, mouse liver tissue |
| Positive IHC detected in | human stomach cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HepG2 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:10-1:100 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
19511-1-AP targets TOR2A in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | torsin family 2, member A |
| Calculated Molecular Weight | 36 kDa |
| Observed Molecular Weight | 40-45 kDa |
| GenBank Accession Number | NM_001085347 |
| Gene Symbol | TOR2A |
| Gene ID (NCBI) | 27433 |
| RRID | AB_10642949 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q8N2E6 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
TOR2A, also named as TORP1, UNQ6408/PRO21181, HEMBA1005096 and PSEC0218, belongs to the clpA/clpB family and Torsin subfamily. TOR2A contain two peptides Salusin-alpha and Salusin-beta. Salusins -alpha and -beta may be endocrine and/or paracrine factors able to increase intracellular calcium concentrations and induce cell mitogenesis. Salusins may also be potent hypotensive peptides.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for TOR2A antibody 19511-1-AP | Download protocol |
| IHC protocol for TOR2A antibody 19511-1-AP | Download protocol |
| WB protocol for TOR2A antibody 19511-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The TOR2A Polyclonal antibody (Cat# 19511-1-AP) has 3 citations. Two appear in Cell Death & Disease (2017, 2022), studying diabetic cardiomyopathy and lung tumorigenesis, respectively. The third is in Liver International (2025), investigating NAFLD and lipid metabolism. All citations use the antibody for Western blot in human samples, spanning research fields of cardiovascular disease, oncology, and hepatic lipid disorders.
| Species | Application | Title |
|---|---|---|
Cell Death Dis Salusin-β contributes to oxidative stress and inflammation in diabetic cardiomyopathy. | ||
Liver Int Knockdown of Salusin-β Downregulates FTO to Inhibit Lipid Synthesis and Promote Lipolysis to Attenuate NAFLD |







